Home › Sclerosing Cholangitis › California
Sclerosing Cholangitis clinical trials in California
7 studies for Sclerosing Cholangitis are looking for participants at sites in California.
Cities in California
A Study to Assess How Well and Safely Elafibranor Works in Adult Participants With Primary Sclerosing Cholangitis
- Southern California Research Center, Coronado
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Aug 31, 2026 · NCT07387549A-LiNK: Improving Outcomes in Autoimmune Liver Disease
- Stanford University, Palo Alto
RecruitingObservational study
All ages · All sexes · Updated Aug 19, 2026 · NCT05750498Primary Sclerosing Cholangitis in Children
- Children's Hospital of Los Angeles, Los Angeles
RecruitingObservational study
Ages 2 to 25 · All sexes · Updated Jul 14, 2026 · NCT04181138Statin Therapy in Primary Sclerosing Cholangitis (PSC): a Multi-omics Study
- Stanford University, Stanford
RecruitingEarly phase 1Healthy volunteers welcome
Ages 18 to 80 · All sexes · Updated Feb 27, 2026 · NCT05912387A Study to Assess the Safety and Efficacy of LB-P8 in Patients With PSC
- University of California Davis, Sacramento
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Oct 24, 2025 · NCT06699121Oral Hymecromone to Treat Adolescents and Adults With Primary Sclerosing Cholangitis.
- Stanford Clinic, Redwood City
- Stanford Clinic, Stanford
RecruitingPhase 2
Ages 14 to 75 · All sexes · Updated Jun 13, 2025 · NCT05295680Treating Primary Sclerosing Cholangitis and Biliary Atresia With Vancomycin
- Sacramento Pediatric Gastroenterology, Sacramento
RecruitingPhase 1Healthy volunteers welcome
2 Weeks – 40 Years · All sexes · Updated Nov 15, 2016 · NCT02137668From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.